Diabetes Discourse

Host: Steven Edelman, MD Guest: Matthew Riddle, MD Multiple choices of insulin therapy have provided a decided advantage to both the healthcare provider and patient living with diabetes. What are the specific benefits of customizing insulin therapy for our patients? Join host Dr. Steven Edelman and his guest, professor of medicine at Oregon Health & Science University, Dr. Matthew Riddle, as they discuss the benefits of standard versus individualized insulin therapy.

Host: Steven Edelman, MD Guest: William Polonsky, PhD, CDE Patients living with diabetes often struggle with motivation, depression and other emotional or behavioral challenges. How can healthcare professionals support their patients in the behavioral aspects of their diabetes care and the emotional challenges of their condition? Join host Dr. Steven Edelman and his guest, founder of the Behavioral Diabetes Institute, Dr. William Polonsky as they discuss the need for understanding and support, what's wrong with 'policing,' and good diabetes etiquette in the management diabetes.

Host: Steven Edelman, MD Guest: Rachel Kim, MD Diabetes may affect the musculoskeletal system in a variety of ways. The metabolic perturbations in diabetes result in changes in the connective tissue. What are current recommendations for healthcare providers as an overall strategy in the treatment of patients living with diabetes? Join host Dr. Steven Edelman and his guest, rheumatologist at the Scripps Clinic, Dr. Rachel Kim, as they discuss musculoskeletal complications, intervention and treatment.

Host: Steven Edelman, MD Guest: Debra Simmons, MD The ALLHAT hypertension study results indicated that less costly, traditional diuretics are more effective than newer medicines at lowering high blood pressure and preventing some forms of heart disease. Join host Dr. Steven Edelman and his guest, endocrinologist and director of the endocrinology, diabetes and metabolism training program at the University of Arkansas Medical Sciences and Central Arkansas Veterans Healthcare System, Dr. Debra Simmons as they the results and implications of the Antihypertensive Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) clinical study.

Host: Steven Edelman, MD Guest: Matthias von Herrath, MD Development of a combination therapy is showing significant promise in type 1 diabetes when caught in the early stages. What are some immuno-therapies currently being evaluated for treating type 1 diabetes? Join host Dr. Steven Edelman and his guest, director of the Center for Type 1 Diabetes Research at the La Jolla Institute for Allergy and Immunology, Dr. Matthias von Herrath, as they discuss histopathology, antigen-specific therapy, anti-CD3d antibodies and more.

Host: Steven Edelman, MD Guest: Nancy Bohannon, MD Will insulin pumps become the preferred therapy for patients with type 2 diabetes who are not at goal? New insulin pump technology and patch pumps are offering a whole new level of customization, an ability to improve glucose control and quality of life. Join host Dr. Steven Edelman and his guest, endocrinologist and director of clinical research at St. Luke’s Hospital, Dr. Nancy Bohannon as they discuss new insulin pump technology.

Host: Steven Edelman, MD Guest: Irwin Goldstein, MD The vascular, neurologic, hormonal and psychological issues associated with the diabetes and metabolic syndromes are commonly the cause of sexual problems. What benefit does a multidisciplinary approach to sexual medical issues bring to people living with diabetes? Join host Dr. Steven Edelman and his guest, director of San Diego Sexual Medicine at Alvarado Hospital in Southern California, Dr. Irwin Goldstein, as they discuss both male and female sexual dysfunction, treatments and a multidisciplinary approach to sexual medical issues.

Host: Steven Edelman, MD Guest: David Marrero, PhD Recent studies done with primary prevention were designed to prove that lifestyle changes could reduce the risk for diabetes in people at high risk of developing the disease. What can we learn from novel pilot programs in the prevention of type 2 diabetes? Join host Dr. Steven Edelman and Dr. David Marrero, director of the Diabetes Translational Research Center at the Indiana University School of Medicine, as they discuss translational research, specific results of the “Plan Forward” program and implications for clinical care.

Host: Steven Edelman, MD Guest: Joe Piscatella According to the National Institutes of Health, 85% of physicians state they are not effective in helping patients make healthy dietary changes. What are the obstacles for our healthcare professionals treating patients with diabetes? Join host Dr. Steven Edelman and his guest, best-selling author and national speaker, Joe Piscatella, as they discuss strategies and techniques for healthcare professionals in helping their patients institute and maintain a healthy diet.

Host: Steven Edelman, MD Guest: Kriss Halpern, JD The current state of coverage for people living with diabetes is stressed with approximately fifteen percent of all diagnosed diabetics with no health insurance, another group at risk of losing their health insurance and the last group paying exorbitant premiums to keep their insurance. How will reform affect healthcare professionals treating patients with diabetes? Join host Dr. Steven Edelman and his guest, attorney specializing in diabetes, Kriss Halpern, as they discuss the elements of proposed healthcare reform as it relates to treating patients with diabetes.

Host: Steven Edelman, MD Guest: Stephen Ponder, MD, CDE The emergence of type 2 diabetes in children and adolescents over the past 20 years represents a shift in pediatric chronic disease. Join host Dr. Steven Edelman and his guest, professor of pediatrics and director of the Children’s Diabetes and Endocrine Center of South Texas at Driscoll Children’s Hospital, Dr. Stephen Ponder, as they discuss key challenges in both diagnosis and medical management of this group.

Host: Steven Edelman, MD Guest: Robert Henry, MD The ACT NOW study examined whether treatment of impaired glucose tolerance in pre-diabetic patients with pioglitazone could prevent or delay the development of type 2 diabetes. Join host Dr. Steven Edelman and his guest, endocrinologist and professor of medicine at the University of California San Diego, Dr. Robert Henry, as they discuss the results and implications for clinical care.

Host: Steven Edelman, MD Guest: Bruce Buckingham, MD The developing artificial pancreas carries tremendous potential for the treatment of diabetes. What is research telling us about the various steps to the implementation of the system? Join host Dr. Steven Edelman and his guest, pediatric endocrinologist and professor of medicine at Stanford University, Dr. Bruce Buckingham, as they discuss design, function, implementation, and obstacles to developing the artificial pancreas.

Host: Steven Edelman, MD Guest: Richard Bergenstal, MD The ACCORD, ADVANCE and VA Diabetes Trials seem to indicate that there is no real benefit of intensive glycemic control on cardiovascular events in patients with type 2 diabetes. Join host Dr. Steven Edelman and his guest, executive director of the International Diabetes Center at Park Nicollet, Dr. Richard Bergenstal, as they discuss the implications on clinical care and benefits of glycemic control.

Host: Steven Edelman, MD Guest: Anne-Marie Felton World Diabetes Day marks the annual global awareness campaign for diabetes by the International Diabetes Federation. The campaign’s theme of "diabetes education and prevention" is scheduled for five years. How will the IDF implement this broad campaign for both the health care professionals and people living with diabetes? Join host Dr. Steven Edelman and his guest, vice president of the International Diabetes Federation, Anne-Marie Felton, as they discuss World Diabetes Day and the need for diabetes education and prevention.

Host: Steven Edelman, MD Guest: Joseph Ma, PharmD Pharmacogenomics is applied to select medications with the goal of optimizing drug therapy: maximizing efficacy, minimizing toxicity, and minimizing pharmacokinetic and pharmacodynamic variability. Join guest host, Dr. Candis Morello and Dr. Joseph Ma, assistant professor of clinical pharmacy at the University of San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, as they discuss the impact of pharmacogenomics in diabetes therapy.

Host: Steven Edelman, MD Guest: Lisa Kroon, PharmD, CD The new class of medications known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which stimulate the pancreas to make more insulin after eating a meal, may be changing the way we treat people with type 2 diabetes. Join guest host, Dr. Candis Morello and her guest, professor of clinical pharmacy in the School of Pharmacy at the University of California San Francisco, Dr. Lisa Kroon, as they discuss the use of DPP-4 therapy in the treatment of type 2 diabetes.

Host: Steven Edelman, MD Guest: Sandra Bourdette The results of the landmark Diabetes Control and Complications Trial proved that intensive management of diabetes can significantly improve diabetes outcomes. The education of both the healthcare professional and patient is a key component in the successful management of diabetes. Join host Dr. Steven Edelman and his guest, executive director of Taking Control of Your Diabetes (TCOYD), Sandra Bourdette, as they discuss the mission and results of their novel approach to diabetes education.

Host: Candis Morello, PharmD, CDE Guest: Sarah Lorentz, PharmD Why are people living with diabetes more likely to die with flu and pneumonia? During flu epidemics, this risk is particularly high when additional risk factors present such as cardiovascular disease and kidney disease. Join guest host Dr. Candis Morello and her guest, pharmacist specializing in ambulatory care, Dr. Sarah Lorentz, as they discuss the reasons immunizations for patients with diabetes are so crucial.

Host: Candis Morello, PharmD, CDE Guest: Brookie Best, PharmD New drug delivery technologies are changing one of the key therapeutic challenges of insulin delivery in the management of diabetes. Join guest host Dr. Candis Morello and her guest, Dr. Brookie Best, assistant clinical professor of pharmacy and pediatrics at University of California San Diego, as they discuss the emerging new technologies being developed in this space.